Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Investview, Inc. (“INVU”) Reports Full Year 2024 Financial Results, Operational Highlights and a Year-End Message from the CEO

In This Article:

Investview, Inc.
Investview, Inc.

$55.4M in Gross Revenue | $8.3M in Net Cash Provided by Operating Activities | Strong Balance Sheet |Share Repurchase Program and Strategic Expansion- for the year ended December 31, 2024

Haverford, PA, March 31, 2025 (GLOBE NEWSWIRE) -- Investview, Inc. (OTCQB: INVU), a diversified financial technology services company that offers multiple business units across key sectors, including a financial education division offering tools, products and content through a global network of independent distributors; a manufacturing division focused on proprietary aesthetics, health, nutrition, & cognitive wellness products for wholesale and retail markets, with strategic plans for global expansion; an early-stage online trading platform that intends to offer self-directed retail brokerage services; and a business unit that owns and operates a sustainable blockchain business focused on bitcoin mining, today reported its full-year 2024 financial results and shared highlights of key operational progress, strategic milestones, and forward-focused initiatives.

Summary Consolidated Financial Highlights:

Results of Operations and Net Cash Provided by Operating Activities - Twelve Months Ended December 31, 2024 vs December 31, 2023

  • Gross Revenue (a Non-GAAP measure) decreased 24.0% to $55.4 million for the twelve months ended December 31, 2024, as compared to $72.9 million for the comparable prior year period.

  • Net Revenue decreased 22.9% to $52.4 million for the twelve months ended December 31, 2024, as compared to $67.9 million for the comparable prior year period.

  • Net income from operations decreased 63.2% to $1.7 million for the twelve months ended December 31, 2024, as compared to $4.6 million for the comparable prior year period.

  • Net cash provided by operating activities increased 36.9%, reaching $8.3 million for the twelve months ended December 31, 2024, as compared to $6.1 million for the comparable prior year period, reflecting the results of our disciplined business model.

Balance Sheet Data-December 31, 2024, vs December 31, 2023

  • Cash and cash equivalents increased by 7.4%, reaching $22.5 million for twelve months ended December 31, 2024, an increase of $1.6 million from $20.9 million at December 31, 2023, even after having repurchased $3.4 million of common stock and $1.1 million for the acquisition of substantially all the assets of Renu Laboratories Inc. during 2024. Our cash balances provide us with working capital that we can direct towards our strategic initiatives and growth investments.

  • Total assets at December 31, 2024 were $31.6 million, a decrease of $2.1 million from $33.7 million of assets at December 31, 2023, mainly due to non-cash depreciation and impairment charges relating to our mining servers and a decrease in deposits with vendors, partially offset by an increase our cash balance, an increase in Bitcoin holdings and the addition of a goodwill balance related to the acquisition of substantially all the assets of Renu Laboratories Inc.

  • Working Capital Balance increased by 30.8% to $16.2 million at December 31, 2024, an increase of $3.8 million from December 31, 2023.

  • Current Ratio is strong, up 14.3%, reaching 2.32 at December 31, 2024, an increase of 0.29 from our previous current ratio of 2.03 at December 31, 2023, confirming our strong balance sheet position.

  • Outstanding debt decreased by 10.0%, to $3.2 million at December 31, 2024, a decrease of $0.4 million, from the $3.6 million of debt at December 31, 2023, with total liabilities also decreasing by $0.5 million during the comparative period.

  • Total stockholders’ equity at December 31, 2024 was $17.2 million, a decrease of $1.6 million or 8.5% from the $18.8 of stockholders’ equity at December 31, 2023, mainly due to the repurchase of common shares during 2024.

  • Common stock issued and outstanding decreased by approximately 20.3% to 1.859 billion shares at the end of December 31, 2024, a decrease of 474 million shares from 2.333 billion shares at December 31, 2023, primarily attributable to strategic stock repurchases aimed at further reducing outstanding share count in an effort to enhance shareholder value.